4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-001178
Chief Patient Supply Officer sold 1,065 shares at $5.33 ($5,674)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lunger John Chief Patient Supply Officer | 2021-01-04 | Sale | −1,065 | $5.33 | $5,674 | 1,760 | D: show line 1 in the form |
| Open-market sales · 1,065 sh · avg $5.33 · $5,674 | |||||||
Loading xslF345X03/tm211506d4_4seq1.xml…